What Has Been the Growth of the Structural Heart Devices Market So Far?
The structural heart devices market has seen considerable growth due to a variety of factors.
• The structural heart devices market has grown significantly in recent years. It will rise from $10.41 billion in 2024 to $11.44 billion in 2025, reflecting a CAGR of 9.9%.
Growth is driven by the trend toward less invasive surgical procedures, the demand for minimally invasive heart devices, ongoing training for healthcare professionals, increasing healthcare expenditure, and rising patient preference for non-invasive treatments.
How Will the Structural Heart Devices Market?
The structural heart devices market is expected to maintain its strong growth trajectory in upcoming years.
• The structural heart devices market is projected to grow to $16.48 billion by 2029, at a CAGR of 9.6%.
Growth is attributed to the aging population, increased awareness of heart health, screening programs, favorable reimbursement policies, and timely regulatory approvals. Key trends include the adoption of transcatheter valve replacement, the development of advanced devices, personalized treatments, hybrid procedures, and remote monitoring integration.
Which Factors Are Boosting Growth In The Structural Heart Devices Market?
The escalation in cardiovascular diseases is projected to drive the expansion of the structural heart device market. Cardiovascular diseases are a collection of afflictions that impact the heart and blood vessels, encompassing issues like coronary artery disease, strokes, and heart attacks. Sedentary living, poor eating habits, climbing obesity figures, smoking, and an elderly population have led to a constant rise in these diseases globally. Structural heart devices are used to treat cardiovascular diseases by mending or replacing defected heart valves, fixing structural faults, and fostering heart function and patient results. For example, the British Heart Foundation released data in September 2024 showing roughly 7.6 million people in the UK have heart and circulatory diseases, including about 4 million men and 3.6 million women. These ailments cause about 27% of all UK deaths, or over 170,000 deaths per year, which breaks down to around 480 deaths per day or one death every three minutes. Consequently, the growing prevalence of cardiovascular diseases is propelling the enlargement of the structural heart device market.
What Key Areas Define The Segmentation Of The Global Structural Heart Devices Market?
The structural heart devices market covered in this report is segmented –
1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems
2) By Procedure: Replacement Procedures, Repair Procedures
3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications
4) By Age Group: Pediatric, Adults
Subsegments:
1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings
2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings
3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders
4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems
Pre-Book The Structural Heart Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Structural Heart Devices Market?
Key players in the structural heart devices industry are innovating with minimally invasive procedures and devices to improve the outcomes for patients, decrease recovery times, and broaden the range of treatments for structural heart ailments. A self-expanding transcatheter aortic valve implantation (TAVI) system is a specialized device for positioning and anchoring a replacement valve in the innate anatomy of the aortic valve, with no need for balloon inflation. In reference to this, Abbott Laboratories, a U.S. firm that produces medical devices and healthcare goods, introduced Navitor, their next generation TAVI system in India in December 2022. Navitor is customized for those suffering from severe aortic stenosis who are at high or extreme surgical risk and it incorporates advanced features such as a unique design to prevent valve leakage. This product enhances Abbott's portfolio of structural heart transcatheter devices, providing physicians and patients with more minimally invasive options for treating heart conditions. Navitor is unique as the only self-expanding TAVI system equipped with intra-annular leaflets and large frame cells, hence improving access to coronary arteries for prospective interventions in coronary artery disease (CAD). Additionally, the new design improves hemodynamics, thereby optimising blood circulation.
Who Are the Key Players In The Structural Heart Devices Market?
Major companies operating in the structural heart devices market are:
• Abbott Laboratories
• Medtronic Plc
• Boston Scientific Corporation
• Terumo Corporation
• Edwards Lifesciences Corporation
• W. L. Gore & Associates Inc.
• Bracco Group
• LivaNova PLC
• Meril Life Sciences Pvt. Ltd.
• CryoLife Inc.
• Braile Biomédica
• TTK Healthcare Limited
• Direct Flow Medical Inc.
• JenaValve Technology Inc.
• Micro Interventional Devices Inc.
• CardioKinetix Inc.
• Xeltis AG
• Ancora Heart Inc.
• JOMDD Inc.
• Valcare Medical
• BioStable Science & Engineering Inc.
• Comed B.V.
• Transcatheter Technologies GmbH
• Navilyst Medical Inc.
What Is The Most Dominant Region In The Structural Heart Devices Market?
North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
